Market Research Report
Global Cough, Cold & Allergy
|Published by||Nicholas Hall & Company||Product code||329294|
Delivery time: 1-2 business days
|Global Cough, Cold & Allergy|
|Published: June 26, 2015||Content info:||
This publication has been discontinued on January 14, 2020.
Nicholas Hall's Global Cough, Cold and Allergy report takes an in-depth look at this cornerstone category, offering detailed analysis of key brands as well as individual subcategories. Featuring year-end 2014 sales data from Nicholas Hall's global OTC database, DB6, this report offers the most up-to-date picture of the current CCA market.
While the overall market has not offered great opportunities for OTC marketers, the allergy subcategory showed continued growth with a 6% rise for the year; Rx-to-OTC switches and the return of previously withdrawn products fuelled this growth. Both topical decongestants and sore throat remedies & medicated confectionery also helped to bolster the overall CCA category, showing strong improvements.
This report covers all major subcategories and profiles 15 countries featuring key trends, regulatory developments and insight into success factors behind leading segments and brands. For OTC marketers looking to continue to build for the future, Nicholas Hall's Global OTC Cough, Cold and Allergy report offers sales forecasts to both 2019 and 2024, while also predicting industry prospects as well as opportunities and threats that may impact individual markets.